Fig 1.
Flow chart of the research process.
Table 1.
Baseline characteristics of subjects.
Fig 2.
Results of the positive rates of each drug group calculated to validate the algorithm.
Table 2.
Results of 38 rank 1 drugs with significant QT prolongation risks.
Table 3.
Hazard and odds ratios for seven drugs with significant QT prolongation risk.